The Archive · 3 posts
Innovating your health! 🌟 RUA Life Sciences (RUA) pioneers medical devices & biomaterials on the LSE. Cutting-edge and life-changing. 💉
RUA Life Sciences interim results show revenue up 6.1%, adjusted EBITDA turning profitable, but cash falls sharply.
June 30, 2026
Showing 2 of 3 posts
RUA Life Sciences pivots to commercial success: revenue doubled and EBITDA turns positive in final results, driven by CDMO growth and a strategic European acquisition.
JoshuaJanuary 30, 2026
RUA Life Sciences hits break-even with 88% revenue surge & strategic ABISS acquisition. Medical device turnaround driven by contract manufacturing growth and bargain asset purchase.
JoshuaJune 25, 2025